Cargando…

Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer

p53 protein has been frequently detected at high levels in the nuclei of human breast cancer cells. We analyzed inununohistochemically the association between nuclear localization of p53 protein and clinical and histological parameters of breast cancer patients. Surgically resected tissues of 73 pri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwaya, Keiichi, Tsuda, Hitoshi, Hiraide, Hoshio, Tamaki, Kuniyoshi, Tamakuma, Syouetsu, Fukutomi, Takashi, Mukai, Kiyoshi, Hirohashi, Setsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918538/ https://www.ncbi.nlm.nih.gov/pubmed/1679056 http://dx.doi.org/10.1111/j.1349-7006.1991.tb02710.x

Ejemplares similares

p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic Grade
por: Tsuda, Hitoshi, et al.
Publicado: (1993)

Immunoreaction at 43 kDa with Anti‐ubiquitin Antibody in Breast Neoplasms
por: Iwaya, Keiichi, et al.
Publicado: (1997)

Clinicopathological Characteristics of Primary Breast Cancer in Older Geriatric Women: A Study of 39 Japanese Patients over 80 Years Old
por: Morishita, Yukio, et al.
Publicado: (1997)

Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological Phenotypes
por: Tsuda, Hitoshi, et al.
Publicado: (1992)

Preferential Occurrence of Breast Carcinomas with Loss of Chromosome 16q and der(16)t(1;16)/der(1;16) in Middle‐aged Patients with Hyperplasia of Mammary Glands
por: Tsuda, Hitoshi, et al.
Publicado: (2000)

Different Incidence of Loss of Heterozygosity on Chromosome 16q between Intraductal Papilloma and Intracystic Papillary Carcinoma of the Breast
por: Tsuda, Hitoshi, et al.
Publicado: (1994)

Histological Factors Associated with Initial Bone Metastasis of Invasive Ductal Carcinoma of the Breast
por: Koyama, Tadaaki, et al.
Publicado: (1999)

High Incidence of p53 Gene Mutation in Human Ovarian Cancer and Its Association with Nuclear Accumulation of p53 Protein and Tumor DNA Aneuploidy
por: Kihana, Toshimasa, et al.
Publicado: (1992)

Fibrotic Focus in Invasive Ductal Carcinoma: An Indicator of High Tumor Aggressiveness
por: Hasebe, Takahiro, et al.
Publicado: (1996)

Clinicopathological Significance of Nuclear Accumulation of Tumor Suppressor Gene p53 Product in Primary Lung Cancer
por: Hiyoshi, Haruhisa, et al.
Publicado: (1992)

Prognostic Value of p53 Protein Accumulation in Cancer Cell Nuclei in Adenocarcinoma of the Uterine Cervix
por: Tsuda, Hitoshi, et al.
Publicado: (1995)

Point Mutation of the E–Cadherin Gene in Invasive Lobular Carcinoma of the Breast
por: Kanai, Yae, et al.
Publicado: (1994)

Heterogeneity of Proliferative Activity in Nodule‐in‐Nodule Lesions of Small Hepatocellular Carcinoma
por: Matsuno, Yoshihiro, et al.
Publicado: (1990)

Squamoid features and expression of involucrin in primary breast carcinoma associated with high histological grade, tumour cell necrosis and recurrence sites.
por: Tsuda, H., et al.
Publicado: (1997)

Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers
por: Umeda, Junko, et al.
Publicado: (2013)

Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma
por: Tsuda, Hitoshi, et al.
Publicado: (1989)

Allelotype Analysis of Common Epithelial Ovarian Cancers with Special Reference to Comparison between Clear Cell Adenocarcinoma with Other Histological Types
por: Okada, Satoshi, et al.
Publicado: (2002)

Aberrant DNA Methylation on Chromosome 16 Is an Early Event in Hepatocarcinogenesis
por: Kanai, Yae, et al.
Publicado: (1996)

A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer
por: Kobayashi, Takayuki, et al.
Publicado: (2013)

Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma
por: Liang, Yu, et al.
Publicado: (2006)

Point Mutation of c‐Ki‐ras Oncogene in Gastric Adenoma and Adenocarcinoma with Tubular Differentiation
por: Kihana, Toshimasa, et al.
Publicado: (1991)

Frequent Loss of Heterozygosity on Chromosomes 16 and 4 in Human Hepatocellular Carcinoma
por: Zhang, Wandong, et al.
Publicado: (1990)

Detection of Epstein‐Barr Virus DNA in a Japanese Case of Lymphoepithelioma‐like Thymic Carcinoma
por: Matsuno, Yoshihiro, et al.
Publicado: (1992)

Actinin-4, a Novel Actin-bundling Protein Associated with Cell Motility and Cancer Invasion
por: Honda, Kazufumi, et al.
Publicado: (1998)

Copy number gain of ACTN4 is associated with poor prognosis in patients with upper urinary tract urothelial carcinoma
por: Kawamura, Kazuki, et al.
Publicado: (2023)

U.S.‐Japan Seminar on “Genomic Instability during Carcinogenesis and Tumor Progression”
por: Harris, Curtis C., et al.
Publicado: (1992)

Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma
por: De Herdt, Maria J., et al.
Publicado: (2016)

Age-dependent changes of p53 and p63 immunoreactivities in the mouse hippocampus
por: Lee, Tae-Kyeong, et al.
Publicado: (2019)

Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of Patients
por: Tsuda, Hitoshi, et al.
Publicado: (1990)

Fibrotic Focus in Invasive Ductal Carcinoma of the Breast: A Histopathological Prognostic Parameter for Tumor Recurrence and Tumor Death within Three Years after the Initial Operation
por: Hasebe, Takahiro, et al.
Publicado: (1997)

High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers
por: Lin, Shih-Chun, et al.
Publicado: (2017)

p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance.
por: Yamaguchi, A., et al.
Publicado: (1993)

An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancer.
por: Walker, R. A., et al.
Publicado: (1989)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

Downregulation of tumor protein 53-inducible nuclear protein 1 expression in hepatocellular carcinoma correlates with poor prognosis
por: Deng, Yan, et al.
Publicado: (2017)

Inhibition of Cell Attachment, Invasion and Metastasis of Human Carcinoma Cells by Anti‐integrin β(1) Subunit Antibody
por: Fujita, Shin, et al.
Publicado: (1992)

Expression of Cadherin‐Catenin Cell Adhesion Molecules, Phosphorylated Tyrosine Residues and Growth Factor Receptor‐tyrosine Kinases in Gastric Cancers
por: Akimoto, Shingo, et al.
Publicado: (1998)

Immunoreactive cutaneous sporotrichosis()()
por: Carvalho, Gustavo de Sá Menezes, et al.
Publicado: (2020)

Ras Farnesylation Inhibitor FTI‐277 Restores the E‐Cadherin/Catenin Cell Adhesion System in Human Cancer Cells and Reduces Cancer Metastasis
por: Nam, Jeong‐Seok, et al.
Publicado: (2002)

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
por: Ahmad, I, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ma5u00pq0o5vcird5c74144fa5